- Country: United States
Taking Ozempic or Zepbound? FDA orders warning about rare vision loss risk
The Food and Drug Administration is requiring new warnings on GLP-1 drugs, including Ozempic, Wegovy and Zepbound, about a potential increased risk of a rare eye condition that can cause permanent vision loss.